Health Care & Life Sciences » Pharmaceuticals | Shanghai Kaibao Pharmaceutical Co. Ltd.

Shanghai Kaibao Pharmaceutical Co. Ltd.

Shanghai Kaibao Pharmaceutical Co. Ltd.
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.19
Market Cap
CNY4.79 B
Shares Outstanding
801.47 M
Public Float
689.19 M

Profile

Address
No. 88, Chengpu Road
Shanghai Shanghai 201401
China
Employees -
Website http://www.xykb.com
Updated 07/08/2019
Shanghai Kaibao Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of modern Chinese medicine. Its medicines are in the form of injection, tablets, hard capsules, granules, mixture, syrup, oral liquid, and Chinese medicine extraction; such as Tanreqing injection, doxofylline capsule, Captopril sustained-release tablets, and Hydrochloride pioglitazone tablets. The company was founded on April 12, 2000 and is headquartered in Shanghai, China.

Financials

View All

Jing Wei Mu
Chairman & Secretary
Shao Yong Liu
Chairman-Supervisory Board